Overview

Characterization of the Pharmacokinetics of a Vaginal Ring With 2.0 g Progesterone in Post-menopausal Women

Status:
Completed
Trial end date:
2019-05-09
Target enrollment:
Participant gender:
Summary
This is a single site, open-label, randomized, single-dose, Phase 1 study in post-menopausal women.
Phase:
Phase 1
Details
Lead Sponsor:
Grünenthal GmbH
Collaborators:
Grünenthal S.A.
Grünenthal, S.A.
Treatments:
Progesterone